Progressive Diffuse Large B Cell Lymphoma — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for progressive diffuse large b cell lymphoma. 15 active patents protecting 1 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

1
Approved drugs
15
Active US patents
46/100
Avg vulnerability
—
Annual revenue covered

Originators in Progressive Diffuse Large B Cell Lymphoma

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck) 15 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating progressive diffuse large b cell lymphoma. Each bar = one year. Y-axis scaled to peak year (3 patents).

2
27
1
28
2
30
1
32
3
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8101582 Decadron method of use 63 2027-12-19
7795316 Decadron method of use 63 2028-08-03
12150896 Decadron method of use 58 2036-10-07
12144889 Decadron method of use 58 2041-04-26
11458041 Decadron method of use 53 2037-11-16
11304961 Decadron method of use 53 2037-12-18
11097061 Decadron method of use 53 2039-06-23
8563027 Decadron method of use 51 2030-02-12
10028965 Decadron method of use 45 2034-05-23
10022502 Decadron method of use 45 2034-06-22

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23
8563027 Decadron method of use 51 2030-02-12
11097061 Decadron method of use 53 2039-06-23
11304961 Decadron method of use 53 2037-12-18

Related